Cytovance Biologics Inc., an Oklahoma City-based pharmaceutical contract manufacturer, will be acquired by a unit of a Chinese company in a $206 million deal, the companies announced Monday.
Cytovance Biologics Inc., an Oklahoma City-based pharmaceutical contract manufacturer, will be acquired by a unit of a Chinese company in a $206 million deal, the companies announced Monday.